Audrey Vabre is an accomplished R&D Product Research Lead at Galderma since September 2021, overseeing innovation strategy and pipeline development for major brands such as Cetaphil, Benzac, and Differin in the Consumer Global Business Unit. Prior to this role, Audrey served as R&D Manager and Cosmetic Formulation Engineer at HORMETA Switzerland from April 2008 to December 2021, where responsibilities included leading R&D laboratory activities and developing luxury skincare products. Earlier experience includes an R&D Project Associate position at Merck Serono, coordinating projects between IT and Clinical/Medical Information departments from April 2006 to April 2008. Audrey Vabre earned a degree from the Faculty of Pharmacy in Montpellier, France, between 2002 and 2006, and completed a Diplôme Universitaire in Regulatory Affairs in Medical Device Industry at ISIFC in 2021.